Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2002 | 09-2001 | 09-2000 | 09-1999 | 09-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,060 | 4,673 | 4,820 | N/A | 19,400 |
| Marketable Securities | N/A | N/A | 13 | N/A | 4,370 |
| Receivables | 12,616 | 12,526 | 18,819 | N/A | 9,700 |
| Inventories | 12,735 | 12,139 | 15,808 | N/A | 5,560 |
| Income taxes - deferred | 998 | 1,635 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 730 |
| TOTAL | $30,375 | $32,502 | $40,798 | $N/A | $39,760 |
| Non-Current Assets | |||||
| PPE Net | 18,005 | 16,726 | 17,504 | N/A | 8,800 |
| Intangibles | 15,957 | 15,762 | 24,014 | 0 | 0 |
| Other Non-Current Assets | 758 | 992 | 2,401 | 0 | 10,560 |
| TOTAL | $34,720 | $33,480 | $43,919 | $N/A | $19,360 |
| Total Assets | $65,095 | $65,982 | $84,717 | $N/A | $59,140 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 943 | 2,132 | 1,700 | N/A | 0 |
| Accounts payable and accrued liabilities | 1,914 | 2,370 | 3,251 | 0 | 1,050 |
| Accrued Expenses | 3,408 | 2,103 | 2,731 | N/A | 2,600 |
| Other current liabilities | 1,407 | 800 | N/A | N/A | 0 |
| TOTAL | $15,249 | $16,368 | $16,619 | $N/A | $3,860 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,626 | 4,349 | 7,159 | N/A | 20,030 |
| Other Non-Current Liabilities | 20,000 | 20,000 | 20,000 | 0 | 0 |
| TOTAL | $25,465 | $26,670 | $31,487 | $N/A | $20,590 |
| Total Liabilities | $40,714 | $43,038 | $48,106 | $N/A | $24,460 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,926 | 32,848 | N/A | N/A | N/A |
| Common Shares | 2,535 | 2,535 | 2,530 | N/A | 2,390 |
| Retained earnings | 1,901 | 892 | 14,889 | N/A | 11,930 |
| Other shareholders' equity | -1,246 | -1,445 | -1,749 | 0 | -290 |
| TOTAL | $24,381 | $22,944 | $36,611 | $N/A | $34,680 |
| Total Liabilities And Equity | $65,095 | $65,982 | $84,717 | $0 | $59,140 |